Further, among individuals with OSA and undergoing continuous positive airway pressure (CPAP) therapy, outcome success was associated with decreased ICAM-1 level and with lower odds of cardiovascular issues [28]. The gene discussed is ICAM1; the disease is obstructive sleep apnea syndrome.